arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ASSEMBLY BIOSCIENCES, INC.

ASMB
$25.49 ▲ +0.09 (+0.35%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
71 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
38
Health
Weak
Bearish
auto_awesome

Analytical Summary

ASSEMBLY BIOSCIENCES, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $480.6M
Dividend Yield
Revenue Growth 38.9%
Op. Margin -47.4%
ROIC -1.6%
FCF / Share $-0.82
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.37M
↑ +38.9%
Net Income Profit after all expenses
$-3.86M
↑ +62.2%
Operating Margin Operating profit as % of sales
-47.4%
↑ +65.7% 11th
FCF / Share Free cash flow per share
$-0.82
↑ +37.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
11
Returns
40
Cash Quality
97

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 71 quarters